CompaniesNEC Oncoimmunity

NEC Oncoimmunity

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

6

By Phase

PHASE1: 1

By Status

ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
Today
NCT05354323
Hover over trial bars to see details

Recent Trials

NCT05354323Lead Sponsor
NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors
PHASE1Active, not recruiting
6 participants
Started: May 5, 2022 · Completed: Dec 31, 2025